MedPath

Study of abnormal avtivity and mutation of tyrosine kinases in Hypereosinophilic syndrome.

Not Applicable
Conditions
Hypereosinophilic syndrome,chronic eosinophilic leukemia
Registration Number
JPRN-UMIN000008655
Lead Sponsor
Kobe University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Corticosteroid or Antiallergic drug effective HES

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Exploration of novel biomarkers in HES/CE
Secondary Outcome Measures
NameTimeMethod
Function analysis of the newly explored biomakers
© Copyright 2025. All Rights Reserved by MedPath